Q. Why haven't we been told who the independent AML researcher is?
A. Their interest comes from the Sheba 2 abstract. But Sheba 2 isn't finished yet.
Also, they haven't decided the trial design yet. Their identity will be revealed after those are both complete.
Q. How can the same CMO sign off on two very different clinical strategies within three months?
A. Words to the effect that the same CMO can do that if she is given very different instructions.
Ann: Race Oncology 2023 Chair's Address & AGM Presentation, page-31
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.040(2.42%) |
Mkt cap ! $276.0M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.66 | $1.61 | $147.2K | 90.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1096 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.62 | 210 | 2 |
View Market Depth
| Last trade - 15.16pm 08/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |